A study published in the journal Endocrinology (2004) reveals that giving Prozac to children may result in a loss of bone mass. The study was conducted on mice and showed an average 9.4% less bone formation in the thighbones of the mice taking Prozac, compared to mice who were not given the drug.
According to another study published in the journal Pediatrics (1999), infants whose mothers took Prozac while breastfeeding grew significantly less than infants whose mothers had discontinued Prozac after delivery. The study concluded: "The data set forth in this study indicate that infants who are breastfed by mothers who take fluoxetine [Prozac] track a growth curve significantly below that of infants breastfed without the medication."
Previously, a study published in the New England Journal of Medicine (1996) found that the birth weight of babies exposed to Prozac during pregnancy was less than those not exposed to Prozac during pregnancy.
According to another study published in the journal Pediatrics (1999), infants whose mothers took Prozac while breastfeeding grew significantly less than infants whose mothers had discontinued Prozac after delivery. The study concluded: "The data set forth in this study indicate that infants who are breastfed by mothers who take fluoxetine [Prozac] track a growth curve significantly below that of infants breastfed without the medication."
Previously, a study published in the New England Journal of Medicine (1996) found that the birth weight of babies exposed to Prozac during pregnancy was less than those not exposed to Prozac during pregnancy.